Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-15T12:50:39.056Z Has data issue: false hasContentIssue false

538 Implementing depression screening services in appointment-based pharmacies: A qualitative observational feasibility study

Published online by Cambridge University Press:  08 May 2026

Brandy Davis
Affiliation:
Auburn University
Natalie Hohmann
Affiliation:
Auburn University
Brent Fox
Affiliation:
Auburn University
Lindsey Hohmann
Affiliation:
Auburn University
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Objectives/Goals: This study aimed to explore the feasibility of implementing sustainable depression screening services within an appointment-based pharmacy. Methods/Study Population: A qualitative observational study was conducted at a rural, appointment-based community pharmacy. Following staff consent, unstructured interviews and workflow observations were performed over a 1-week period to characterize existing processes and identify potential integration points for screening. Field notes from observations and interviews were supplemented with an anonymous Qualtrics survey assessing perceived barriers and facilitators to depression screening implementation. Results/Anticipated Results: The pharmacy filled approximately 200 prescriptions daily and employed one pharmacist and two to four bilingual technicians serving a predominantly Hispanic population. Both the pharmacist and staff were supportive of implementing depression screening and viewed it as compatible with their MedSync workflow. Reported barriers included the lack of a private counseling area and concerns regarding patient comfort discussing mental health due to stigma. Discussion/Significance of Impact: Appointment-based pharmacies are well suited to integrate depression screening into existing workflows. Future implementation efforts should address structural and stigma-related barriers to optimize feasibility and sustainability.

Information

Type
Translational integrative and engagement in research
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2026. The Association for Clinical and Translational Science